Escolar Documentos
Profissional Documentos
Cultura Documentos
VOLUME 52
May
NUMBER 3
Original Article
Abstract
Background Dengue viral infection may cause mild to severe
clinical manifestations, with or without bleeding. A number of
factors may cause bleeding in patients with dengue. However,
health providers may be unable to perform the examinations
required to sufficiently predict the risk of bleeding.
Objective To find risk factors for bleeding using peripheral blood
examinations in children with dengue infection.
Methods This cross-sectional study was conducted at the
3HGLDWULF :DUG RI WKH 'U 6DLIXO $QZDU *HQHUDO +RVSLWDO
0DODQJ IURP -DQXDU\ WR 'HFHPEHU :H LQFOXGHG
FKLOGUHQ DJHG WR \HDUV ZLWK GHQJXH YLUDO LQIHFWLRQ DV
FRQILUPHGE\WKH:+2FULWHULDDQGVHURORJ\3HULSKHUDO
EORRGH[DPLQDWLRQVZHUHPDGHGDLO\GHSHQGLQJRQWKHSDWLHQWV
condition. We classified the bleeding status into non-bleeding,
petechial bleeding (mild hemorrhage), and mucosal bleeding
VHYHUHKHPRUUKDJH:HUHFRUGHGVXEMHFWVEOHHGLQJVWDWXVDW
WKHWLPHRIWKHLUKLJKHVWSDFNHGFHOOYROXPH3&9DQGUHFRUGHG
their leukocyte and platelet counts at that time. We computed
WKHSDUDPHWHUVPHGLDQVDQGFRPSDUHGWKHPWREOHHGLQJVWDWXV
E\ &KLVTXDUH WHVW )RU VLJQLILFDQW 3 DVVRFLDWLRQV ZH
FDOFXODWHGWKH25RGGVUDWLRZLWKDFRQILGHQFHLQWHUYDO
$OOSDWLHQWVZHUHWUHDWHGDFFRUGLQJWRWKH:+2GHQJXH
guidelines.
Results 7KHUH ZHUH DOO VXEMHFWV ZLWK GHQJXH DQG
VXEMHFWVKDGFRPSOHWHGDWDZLWKEOHHGLQJSHWHFKLDO
PXFRVDO EOHHGLQJ DQG ZLWKRXW EOHHGLQJ 7KH PHGLDQ
3&9ZDVZKLOHPHGLDQSODWHOHWFRXQWZDV/
DQGPHGLDQOHXNRF\WHFRXQWZDV/7KH25RI3&9
!IRUEOHHGLQJZDV&,WR7KH25
RISODWHOHWFRXQW/IRUEOHHGLQJZDV&,
WRFRPSDUHGWRSODWHOHWFRXQW!/7KH
25RISODWHOHWFRXQW/IRUPXFRVDOEOHHGLQJZDV
&,WR&KLVTXDUHDQDO\VLVIRUOHXNRF\WH
count showed it was not associated with bleeding in dengue
3
Methods
This cross-sectional study was undertaken from
-DQXDU\ WR 'HFHPEHU :H LQFOXGHG DOO
FKLOGUHQ WR \HDUV ROG DGPLWWHG WR 'U 6DLIXO
Anwar General Hospital, with dengue viral infection
only. The dengue diagnoses were made according to
:+2 FULWHULD DQG FRQILUPHG E\ VHURORJ\ $V
suggested in the guidelines, hematologic examinations
ZHUHSHUIRUPHGGDLO\GHSHQGLQJRQSDWLHQWVFOLQLFDO
FRQGLWLRQ LQFOXGLQJ 3&9 OHYHOV SODWHOHW FRXQWV
DQGOHXNRF\WHFRXQWV7KHKLJKHVWPHGLDQ3&9ZDV
recorded with the assumption that it represented the
critical phase (leakage period). Median leukocyte
Results
7KHUHZHUHSDWLHQWVZLWKGHQJXHYLUDOLQIHFWLRQ
EXWRQO\KDGFRPSOHWHGDWD$PRQJWKHVH
KDGEOHHGLQJSHWHFKLDOEOHHGLQJPXFRVDO
EOHHGLQJ ZKLOH KDG QR EOHHGLQJ 7KH PHGLDQ
3&9ZDVPHGLDQSODWHOHWVFRXQWZDV
/DQGPHGLDQOHXNRF\WHVFRXQWZDV/7KH
numbers of male and female patients with dengue
viral infection were not significantly different. The
incidence of petechial bleeding appeared greater than
mucosal bleeding in each of the above blood parameter
groups. The basic characteristics of subjects are shown
LQ7DEOH
Table 2 shows the OR of predicting the risk of
EOHHGLQJ 6XEMHFWV ZLWK D 3&9 ! KDG
WLPHV WKH ULVN RI EOHHGLQJ WKDQ WKRVH ZLWK 3&9
7KH OHXNRF\WHV FRXQW ZDV QRW VLJQLILFDQWO\
DVVRFLDWHG ZLWK EOHHGLQJ WHQGHQF\ 6XEMHFWV ZLWK
SODWHOHWVFRXQW/KDGWLPHVWKHULVN
for mucosal bleeding than those with platelet count
!/
Non-bleeding
(n=80)
Petechial bleeding
(n=120)
Mucosal bleeding
(n=82)
Total
(n=282)
46
34
63
57
44
38
153
129
Median PCV
Median leucocytes count
Median platelets count
36.8%
3,400/ L
51,000/ L
52
28
53
67
37
45
142
140
Leucocytes count
< 3,400/L
Leucocytes count
>3,400/L
46
53
44
143
34
67
38
139
Platelets count
< 51,000/L
Platelets count
>51,000/L
30
63
55
148
50
57
27
134
124
32
36
61
29
Table 2.#UUQEKCVKQPQHDNGGFKPIVQ2%8NGWMQE[VGUEQWPVCPFRNCVGNGVUEQWPV
NonBleeding
bleeding
n=202
n=80
PCV, n
> 36.8%
<36.7%
.GWMQE[VGEQWPVP
< 3,400/L
>3,400/L
Chi-square P=0.128
Platelet count, n
< 51,000/L
>51,000/L
28
52
112
90
46
34
97
105
30
50
118
84
OR
(95% CI)
2.31
(1.35 to 3.95)
2.34
(1.37 to 3.99)
Non- Petechial
bleeding bleeding
n=80
n=120
28
52
67
53
46
34
53
67
30
50
63
57
Discussion
Dengue has a wide spectrum of clinical presentations,
often with unpredictable clinical evolution and
outcomes. While most patients recover following
a self-limiting, non-severe clinical course, a small
proportion progress to severe disease, mostly
characterized by plasma leakage with or without
hemorrhage.6 7KH :+2 FULWHULD JXLGHOLQH
groups symptomatic dengue virus infections into three
FDWHJRULHVXQGLIIHUHQWLDWHGIHYHUGHQJXHIHYHU')
OR
2.35
(1.31 to 4.21)
1.84
(1.03 to 3.28)
Non- Mucosal
bleeding bleeding
n=80
n=82
28
52
45
37
46
34
44
38
30
50
55
27
OR
(95% CI)
2.26
(1.20 to 4.25)
3.4
(1.78 to 6.48)
References
.KULVQDPXUWL & .DOD\DQDURRM 6 &XWWLQJ 0$ 3HDW 5$
5RWKZHOO 6: 5HLG 7- HWDO 0HFKDQLVPV RI KHPRUUKDJH
in dengue without circulatory collapse. Am J Trop Med.
8..,QIHNVLGDQ3HGLDWUL7URSLV,QIHNVLYLUXVGHQJXH,Q
6RHGDUPR663*DUQD++DGLQHJRUR656DWDUL+,HGLWRUV
Buku ajar infeksi dan pediatri tropis. 2ndHG-DNDUWD%DGDQ
3HQHUELW,'$,S
&DUORV&&2LVKL.&LQFR07''0DSXD&$,QRXH6&UX]
DJM, et al. Comparison of clinical features and hematologic
abnormalities between dengue fever and dengue hemorrhargic feveUDPRQJFKLOGUHQLQWKH3KLOLSSLnes. Am J Trop Med
+\J
6KX3<+XDQJ-+&XUUHQWDGYDQFHVLQGHQJXHGLDJQRVLV
&OLQ'LDJQ/DE,PPXQRO
0DUWLQD %(( .RUDND 3 2VWHUKDXV $'0( 'HQJXH YLUXV
SDWKRJHQHVLV DQ LQWHJUDWHG YLHZ &OLQ 0LFURELRO 5HY
:RUOG+HDOWK2UJDQL]DWLRQ'HQJXHJXLGHOLQHVIRUGLDJQRVLV
WUHDWPHQWSUHYHQWLRQDQGFRQWURO
%DOPDVHGD$+DPPRQG613HUH]0$&XDGUD56RODQR6
Rocha J, et al. 6KRUWUHSRUWDVVHVVPHQWRIWKH:RUOG+HDOWK
Organization scheme for classification of dengue severity in
1LFDUDJXD$P-7URS+\J
+DPPRQG 61 %DOPDVHGD $ 3HUH] / 7HOOH] < 6DERULR
6,0HUFDGR-&Differences in dengue severity in infants,
children, and adults in a 3-year hospital-based study in
1LFDUDJXD$P-7URS0HG+\J
*LEERQV599DXJKQ':'HQJXHDQHVFDODWLQJSUREOHP
%0-
3KXRQJ&;71KDQ17.QHHQ57KX\377KLHQ&91JD
NTT, et al. Clinical diagnosis and assessment of severity of
FRQILUPHGGHQJXHLQIHFWLRQVLQ9LHWQDPHVHFKLOGUHQLVWKH
:RUOG +HDOWK 2UJDQL]DWLRQ FODVVLILFDWLRQ V\VWHP KHOSIXO"
$P-7URS0HG+\J
6RX]D'*)DJXQGHV&76RXVD/3$PDUDO)$6RX]D56
6RX]D$/HWDOEssential role of platelet-activating factor
UHFHSWRULQWKHSDWKRJHQHVLVRIGHQJXHYLUXVLQIHFWLRQ31$6
$VVXQFDRMiranda I, Amaral FA, Bozza FA, Fagundes CT,
6RXVD /3 6RX]D '* HW DO Contribution of macrophage
migration inhibitory factor to the pathogenesis of dengue
YLUXVLQIHFWLRQ)$6(%-
/LQ<6<HK70/LQ&):DQ6:&KXDQJ<&+VX7.
et al. Molecular mimicry between virus and host and its
implications for dengue disease pathogenesis. Exp Biol Med.
&KHQ 0& /LQ &) /HL +< /LQ 6& /LX +6 <HK 70 HW
al. Deletion of the C-terminal region of dengue virus
QRQVWUXFWXUDOSURWHLQ16DEROLVKHVDQWL16PHGLDWHG
platelet dysfunction and bleeding tendency. J Immunol.
:LOOV % 1JRF 79 9DQ 17+ 7KX\ 777 7KX\ 771
DungNM, et al. Hemostatic changes in Vietnamese children
with mild dengue correlate with the severity of vascular leakage
UDWKHUWKDQEOHHGLQJ$P-7URS0HG+\J